• Please log in or register to access this feature.

Functional Urology

You have full text access to this OnlineOpen article

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria

  1. Seiji Matsumoto*,
  2. Kazumi Hashizume,
  3. Naoki Wada,
  4. Jyunichi Hori,
  5. Gaku Tamaki,
  6. Masafumi Kita,
  7. Tatsuya Iwata,
  8. Hidehiro Kakizaki

Article first published online: 26 OCT 2012

DOI: 10.1111/j.1464-410X.2012.11591.x

Issue

BJU International

BJU International

Volume 111, Issue 4, pages 647–652, April 2013

Additional Information

How to Cite

Matsumoto, S., Hashizume, K., Wada, N., Hori, J., Tamaki, G., Kita, M., Iwata, T. and Kakizaki, H. (2013), Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria. BJU International, 111: 647–652. doi: 10.1111/j.1464-410X.2012.11591.x

Author Information

  1. Asahikawa Medical University, Renal and Urological Surgery, Asahikawa, Hokkaidou, Japan

* Correspondence: Seiji Matsumoto MD, PhD, Asahikawa Medical University, Renal and Urological Surgery, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido 078-8510, Japan.
e-mail: matsums@asahikawa-med.ac.jp

  1. Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms

Publication History

  1. Issue published online: 2 APR 2013
  2. Article first published online: 26 OCT 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (240K)

References

  • 1
    Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Subcommittee of the International Continence Society. Neurourol Urodyn 2002; 21: 167–178
    Direct Link:
  • 2
    Milsom I, Abrams P, Cardozo L et al. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 2001; 87: 760–766
    Direct Link:
  • 3
    Stewart WF, Van Rooyen JB, Cundiff GW et al. Prevalence and burden of overactive bladder in the United States. World J Urol 2003; 20: 327–336
  • 4
    Homma Y, Yamaguchi O, Hayashi K, Neurogenic Bladder Society Committee. An epidemiological survey of overactive bladder symptoms in Japan. BJU Int 2005; 96: 1314–1318
    Direct Link:
  • 5
    Dalton CB, Drossman DA. Diagnosis and treatment of irritable bowel syndrome. Am Fam Physician 1997; 55: 875–880, 883–5
  • 6
    Drossman DA, Whitehead WE, Camilleri M et al. Irritable bowel Syndrome: a technical review for practice guideline development. Gastroenterology 1997; 112: 2120–2137
  • 7
    Heaton KW, Oettle GJ. Bowel symptoms and the pelvic floor. Lancet 1986; 24: 1207
  • 8
    Longstreth GF, Wolde-Tsadik G. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics, and clinical correlates. Dig Dis Sci 1993; 38: 1581–1589
  • 9
    Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991; 100: 998–1005
  • 10
    Miwa H. Prevalence of irritable bowel syndrome in Japan: internet survey using Rome III criteria. Patient Prefer Adherence 2008; 2: 143–147
  • 11
    Whorwell PJ, Lupton EW, Erduran D, Wilson K. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut 1986; 27: 1014–1017
  • 12
    Cukier JM, Cortina-Borja M, Brading AF. A case-control study to examine any association between idiopathic detrusor instability and gastrointestinal tract disorder, and between irritable bowel syndrome and urinary tract disorder. Br J Urol 1997; 79: 865–878
    Direct Link:
  • 13
    Whitehead WE, Palsson OS, Levy RR et al. Comorbidity in Irritable Bowel Syndrome. Am J Gastroenterol 2007; 102: 2767–2776
    Direct Link:
  • 14
    Agrawal A, Khan MH, Whorwell PJ. Irritable bowel syndrome in the elderly: a overlooked problem? Dig Liver Dis 2009; 41: 721–724
  • 15
    Guo YJ, Ho CH, Chen SC et al. Lower urinary tract symptoms in women with irritable bowel syndrome. Int J Urol 2010; 17: 175–181
    Direct Link:
  • 16
    Novi JM, Jeronis S, Srinivas S et al. Risk of irritable bowel syndrome and depression in women with interstitial cystitis: a case-control study. J Urol 2005; 174: 937–940
  • 17
    Nickel JC, Tripp DA, Pontari M et al. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J Urol 2010; 184: 1358–1363
  • 18
    Qin C, Malykhina AP, Akbarali HI, Foreman RD. Cross-organ sensitization of lumbosacral spinal neurons receiving urinary bladder input in rats with inflamed colon. Gastroenterology 2005; 129: 1967–1978
  • 19
    Bielefeldt K, Lamb K, Gebhart GF. Convergence of sensory pathways in the development of somatic and visceral hypersensitivity. Am J Physiol 2006; 291: G658–665
  • 20
    Qin C, Foreman RD. Viscerovisceral convergence of urinary bladder and colorectal inputs to lumbosacral spinal neurons in rats. Neuroreport 2004; 15: 467–471
  • 21
    Christianson JA, Liang R, Ustinova EE et al. Convergence of bladder and colon sensory innervation occurs at the primary afferent level. Pain 2007; 128: 235–243
  • 22
    Homma Y, Yoshida M, Seki N et al. Symptom assessment tool for overactive bladder syndrome – overactive bladder symptom score. Urology 2006; 68: 318–323
  • 23
    Yamaguchi O, Nishizawa O, Takeda M et al. Clinical guidelines for overactive bladder. Int J Urol 2009; 16: 126–142
    Direct Link:
  • 24
    Thompson WG, Drossman DA, Talley NJ et al. Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm. In Drossman DA , Corazziari E , Delvaux M et al. eds, Rome III; The Functional Gastrointestinal Disorders, 3rd edn. McLean: Degnon Associates, 2006: 917–951
  • 25
    Longstreth GF, Thompson WG, Chey WD et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480–1491
  • 26
    Fukudo S, Hongo M, Matsueda K, Drossman DA. The Japanese Version of Rome III: the Functional Gastrointestinal Disorders, 3rd edn. Tokyo: KYOWA KIKAKU Ltd., 2008
  • 27
    Atkinson W, Lockhart S, Whorwell PJ et al. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome. Gastroenterology 2006; 130: 34–43
  • 28
    Mariappan P, Alhasso A, Ballantyne Z et al. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 2007; 51: 67–74
  • 29
    Coates MD, Mahoney CR, Linden DR et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126: 1657–1664
  • 30
    Garvin B, Wiley JW. The role of serotonin in irritable bowel syndrome: implications for management. Curr Gastroenterol Rep 2008; 10: 363–368
View Full Article with Supporting Information (HTML) Get PDF (240K)